Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation.
DICER1
Sertoli-Leydig cell tumor
pleuropulmonary blastoma
thoracic tumor
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
23
07
2021
received:
21
06
2021
accepted:
28
07
2021
pubmed:
17
8
2021
medline:
19
3
2022
entrez:
16
8
2021
Statut:
ppublish
Résumé
A 2-year-old boy presented with a large cystic and solid chest mass arising from the lung, radiographically consistent with pleuropulmonary blastoma (PPB). He underwent right lower lobectomy with resection of a well-circumscribed, mixed solid and cystic mass. The solid areas were composed of cords and nests of tumor cells in the myxoid stroma and retiform foci whose pathologic and immunophenotypic findings were consistent with a sex cord-stromal tumor with features of a Sertoli-Leydig cell tumor. Tumor testing showed a pathogenic variant in the DICER1 RNase IIIb hotspot domain. Family history was suggestive of DICER1 germline pathogenic DICER1 variation in absence of a detectable germline variant. He received 12 cycles of chemotherapy with ifosfamide, vincristine, dactinomycin and doxorubicin (IVADo) and surgery with complete response. One year after completion of chemotherapy, imaging studies showed concern for recurrence confirmed by thorascopic biopsy of a pleural-based mass. He is currently receiving cisplatin-based chemotherapy with reduction in tumor size. Review of the literature showed no similar cases; however, review of our pathology files revealed a single similar case of anterior mediastinal Sertoli cell tumor in a 3-year-old girl.
Identifiants
pubmed: 34398502
doi: 10.1002/pbc.29284
pmc: PMC8463509
mid: NIHMS1729158
doi:
Substances chimiques
DICER1 protein, human
EC 3.1.26.3
Ribonuclease III
EC 3.1.26.3
DEAD-box RNA Helicases
EC 3.6.4.13
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e29284Subventions
Organisme : NCI NIH HHS
ID : L40 CA171135
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA143167
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA244940
Pays : United States
Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
J Oncol. 2008;2008:619637
pubmed: 19266086
F1000Res. 2015 Jul 10;4:214
pubmed: 26925222
Science. 2009 Aug 21;325(5943):965
pubmed: 19556464
J Med Genet. 2021 Mar 29;:
pubmed: 33782093
Gynecol Oncol. 2011 Aug;122(2):246-50
pubmed: 21501861
Am J Surg Pathol. 1985 Aug;9(8):543-69
pubmed: 3911780
Mod Pathol. 2015 Dec;28(12):1603-12
pubmed: 26428316
Pediatr Blood Cancer. 2015 Dec;62(12):2114-9
pubmed: 26206391
Mo Med. 2019 May-Jun;116(3):206-210
pubmed: 31527943
Gynecol Oncol. 2017 Dec;147(3):521-527
pubmed: 29037807
Mod Pathol. 2005 Feb;18 Suppl 2:S81-98
pubmed: 15502809
Hum Pathol. 2017 Jul;65:1-14
pubmed: 28445692
Clin Cancer Res. 2018 May 15;24(10):2251-2261
pubmed: 29343557
Diagn Pathol. 2019 Apr 1;14(1):27
pubmed: 30935425
N Engl J Med. 2012 Jan 19;366(3):234-42
pubmed: 22187960
Cancer. 1980 Mar 1;45(5):985-90
pubmed: 7020914
Mod Pathol. 2014 Sep;27(9):1267-80
pubmed: 24481001
Pediatr Blood Cancer. 2021 Jun;68 Suppl 4:e29017
pubmed: 33760357
Hum Pathol. 2016 Jul;53:114-20
pubmed: 27036314